PCN338 KEY DRIVERS OF HEALTH TECHNOLOGY ASSESSMENT DECISIONS FOR RELAPSED-REFRACTORY MULTIPLE MYELOMA TREATMENTS; A COUNTRY COMPARISON.
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.533
https://www.valueinhealthjournal.com/article/S1098-3015(19)32911-0/fulltext
Title :
PCN338 KEY DRIVERS OF HEALTH TECHNOLOGY ASSESSMENT DECISIONS FOR RELAPSED-REFRACTORY MULTIPLE MYELOMA TREATMENTS; A COUNTRY COMPARISON.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32911-0&doi=10.1016/j.jval.2019.09.533
First page :
Section Title :
Open access? :
No
Section Order :
10457